Clinical perspectives on unregulated peptide administration.
Academic medical literature and clinical toxicology advisories have established definitive positions regarding the human administration of non-approved synthetic peptides obtained through online channels. Lyotide Scientific endorses these clinical warnings without reservation and aligns its distribution framework accordingly.
Harvard Health Publishing
“As a clinician, I do not recommend injecting yourself with peptides.”
Dr Pieter Cohen, Associate Professor of Medicine, Harvard Medical School
“When you’re talking about peptides being promoted online, those health claims have not been vetted by any expert group, the FDA, or anyone else.”
Dr Pieter Cohen, quoted in Harvard Health Publishing
Academic literature highlights the widespread online commercialization of unapproved investigational compounds under the pro forma designation of “research chemical” or “research use only,” frequently sold directly to end consumers. Lyotide Scientific repudiates this consumer-facing gray-market posture.
| Operational boundaries | |
|---|---|
| Qualified enterprise sphere | Prohibited consumer sphere |
| Verified commercial R&D accounts | Retail consumers / general public |
| In vitro laboratory protocols | In vivo human or veterinary use |
| Certified laboratory facilities | Residential / private delivery |
| Neutral, unlabeled primary units | Finished consumer-packaged goods |
Commercial boundaries and governance
We do not seek to qualify or distinguish our inventory from academic clinical warnings through promotional claims. Our portfolio comprises non-approved chemical reagents that have not undergone the safety, efficacy, and toxicology evaluations required for human clinical approval by the United States Food and Drug Administration (FDA) or foreign equivalents.
- Client demographics
- Materials are restricted to commercial enterprises, biotechnology organizations, universities, and accredited research facilities. We do not fulfill orders to consumers, patients, or dispensing medical practices.
- Unit packaging
- Shipped in unprinted ten-vial institutional boxes accompanied by analytical synthesis paperwork. Products contain no dosing guidelines or therapeutic guidance.
- No therapeutic indications
- Lyotide Scientific makes no claims—expressed or implied—regarding the physiological efficacy, bioactivity, or clinical utility of any distributed substance.
- Individual consumers
- Individuals seeking peptides for therapeutic, cosmetic, or performance applications are strictly ineligible to hold an account with Lyotide Scientific and are urged to consult a board-certified physician.
Related reading: analytical scope and contaminant profiles and compounding regulatory landscape.
Taylor, M. (Reviewed by Cohen, P., MD). (2026, July 7). Peptides: What they are, potential benefits, and safety concerns. Harvard Health Publishing. Read the original article. Quotations are Harvard Health’s; the commentary is ours. Harvard Health and Dr Pieter Cohen do not endorse, sponsor, or maintain affiliation with Lyotide Scientific.